Cara Therapeutics
CARA
#10367
Rank
A$12.21 M
Marketcap
A$8.01
Share price
-2.56%
Change (1 day)
1,798.47%
Change (1 year)

Cara Therapeutics (CARA) - Total assets

Total assets on the balance sheet as of December 2024 : A$65.98 Million

According to Cara Therapeutics 's latest financial reports the company's total assets are A$65.98 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cara Therapeutics - Total assets on balance sheet (from 2012 to 2024)

Total assets by year

Year Total assets Change
2024-12-31A$70.46 M-61.85%
2023-12-31A$0.18 B-31.03%
2022-12-31A$0.26 B-21.42%
2021-12-31A$0.34 B-3.36%
2020-12-31A$0.35 B5.98%
2019-12-31A$0.33 B22.84%
2018-12-31A$0.27 B118%
2017-12-31A$0.12 B40.32%
2016-12-31A$88.54 M-41.83%
2015-12-31A$0.15 B122.73%
2014-12-31A$68.34 M237.13%
2013-12-31A$20.27 M280.49%
2012-12-31A$5.32 M-48.87%
2011-12-31A$10.42 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Trevena
TRVN
A$28.88 M-56.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
A$30.7 M-53.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.24 B 476,161.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$290.28 B 439,847.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.12 B 86.13%๐Ÿ‡บ๐Ÿ‡ธ USA